Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDe La Rue Regulatory News (DLAR)

  • This share is currently suspended. It was suspended at a price of 130.00
  • There is currently no data for DLAR

Trading Update

30 Oct 2019 07:00

RNS Number : 5431R
De La Rue PLC
30 October 2019
 

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No.596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

30 October 2019

 

 

DE LA RUE PLC

TRADING UPDATE

 

De La Rue plc ("De La Rue") today announces a trading update from 1 April 2019 to date.

 

De La Rue expects H1 2019/20 adjusted operating profits for the half year ended 28th September 2019 to be low-to-mid single digit millions. Full year 2019/20 adjusted operating profit will be significantly lower than market expectations.

 

Management, led by the new CEO, is conducting a detailed review of the business and will update the market further when it reports its H1 2019/20 results on 26 November 2019.

 

De La Rue plc's LEI code is 213800DH741LZWIJXP78

Enquiries:

 

De La Rue plc +44 (0)1256 605322

Paul Sharma Head of Investor Relations

 

Brunswick Group LLP +44 (0)207 404 5959

Azadeh Varzi

Stuart Donnelly

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTPGGQPUUPBPUB
Date   Source Headline
13th Dec 20249:24 amRNSForm 8.5 (EPT/RI) - De La Rue plc
12th Dec 20243:36 pmRNSResponse to speculation
12th Dec 20247:00 amRNS2024/2025 HALF YEAR RESULTS
27th Nov 20247:00 amRNSNotice of Results
21st Nov 202412:52 pmRNSHolding(s) in Company
13th Nov 20249:00 amRNSAppointment of joint broker
1st Nov 20249:43 amRNSTotal Voting Rights
21st Oct 202410:03 amRNSHolding(s) in Company
15th Oct 20247:00 amRNSProposed sale of Authentication for £300m
25th Sep 20243:49 pmRNSAGM Statement, trading update & strategic update
9th Aug 20244:33 pmRNSNotice of AGM
1st Aug 202410:03 amRNSTotal Voting Rights
31st Jul 20242:07 pmRNSHolding(s) in Company
30th Jul 20243:39 pmRNSDirector/PDMR Shareholding
30th Jul 20243:32 pmRNSAnnual Financial Report
25th Jul 20247:00 amRNS2024 Full Year Results
9th Jul 20244:22 pmRNSDirector/PDMR Shareholding
1st Jul 202412:11 pmRNSBlock listing Interim Review
1st Jul 202412:05 pmRNSTotal Voting Rights
27th Jun 20243:48 pmRNSHolding(s) in Company
30th May 20247:00 amRNSStrategic Update
2nd May 202411:39 amRNSHolding(s) in Company
17th Apr 20247:00 amRNSPre-Close Trading Statement
16th Apr 202411:52 amRNSHolding(s) in Company
16th Apr 202410:59 amRNSHolding(s) in Company
3rd Apr 20247:00 amRNSExtension of contract with Microsoft
2nd Apr 202411:25 amRNSTotal Voting Rights
7th Mar 20241:04 pmRNS2023 AGM Voting Update
23rd Feb 20242:06 pmRNSAdditional Listing
29th Jan 20244:14 pmRNSHolding(s) in Company
26th Jan 20244:38 pmRNSDirector/PDMR Shareholding
18th Jan 20243:19 pmRNSHolding(s) in Company
18th Jan 202412:13 pmRNSHolding(s) in Company
2nd Jan 202411:33 amRNSBlock listing Interim Review
21st Dec 20233:51 pmRNSHolding(s) in Company
19th Dec 20237:00 amRNS2023/24 half year results
27th Nov 20232:53 pmRNSHolding(s) in Company
1st Nov 20231:51 pmRNSTotal Voting Rights
30th Oct 202311:05 amRNSHolding(s) in Company
13th Oct 202310:27 amRNSDirector/PDMR Shareholding
6th Oct 20237:00 amRNSPre-close Trading Statement
2nd Oct 202311:47 amRNSTotal Voting Rights
20th Sep 202312:59 pmRNSDirector/PDMR Shareholding
13th Sep 20231:09 pmRNSHolding(s) in Company
7th Sep 20231:59 pmRNSResult of AGM
7th Sep 20237:00 amRNSAGM statement and trading update
4th Sep 202312:36 pmRNSHolding(s) in Company
1st Sep 20231:15 pmRNSTotal Voting Rights
14th Aug 20233:30 pmRNSHolding(s) in Company
11th Aug 20232:58 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.